ECHQ.F Stock Overview
Provides artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia and the United Kingdom. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Echo IQ Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.06 |
52 Week High | AU$0.06 |
52 Week Low | AU$0.06 |
Beta | 0.89 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
ECHQ.F | US Software | US Market | |
---|---|---|---|
7D | 0% | 2.9% | 2.2% |
1Y | n/a | 25.8% | 31.6% |
Return vs Industry: Insufficient data to determine how ECHQ.F performed against the US Software industry.
Return vs Market: Insufficient data to determine how ECHQ.F performed against the US Market.
Price Volatility
ECHQ.F volatility | |
---|---|
ECHQ.F Average Weekly Movement | n/a |
Software Industry Average Movement | 7.6% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.7% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ECHQ.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ECHQ.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Kimber Rothwell | www.echoiq.ai |
Echo IQ Limited provides artificial intelligence diagnostics tool that enhance the diagnosis of structural heart disease in Australia and the United Kingdom. The company also EchoSolvTM, a software for identification Aortic Stenosis heart condition. It primarily serves physicians and health systems.
Echo IQ Limited Fundamentals Summary
ECHQ.F fundamental statistics | |
---|---|
Market cap | US$44.47m |
Earnings (TTM) | -US$4.26m |
Revenue (TTM) | US$519.97k |
85.5x
P/S Ratio-10.4x
P/E RatioIs ECHQ.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ECHQ.F income statement (TTM) | |
---|---|
Revenue | AU$781.57k |
Cost of Revenue | AU$2.95m |
Gross Profit | -AU$2.17m |
Other Expenses | AU$4.24m |
Earnings | -AU$6.41m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.013 |
Gross Margin | -277.96% |
Net Profit Margin | -820.17% |
Debt/Equity Ratio | 0% |
How did ECHQ.F perform over the long term?
See historical performance and comparison